Department of Medicine and Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA.
Ann Pharmacother. 2010 Apr;44(4):733-6. doi: 10.1345/aph.1M666.
Warfarin is prescribed to millions of Americans for the management of thromboembolism and is a common cause of adverse events. Optimizing warfarin therapy has been the focus of national quality improvement initiatives. Anticoagulation clinics have been demonstrated to result in better outcomes than usual care. Nevertheless, Highmark Medicare Services recently issued a provider bulletin on anticoagulation clinic visit reimbursement that we believe will adversely affect the care for patients on anticoagulation. In this commentary, we review the potential unintended consequences of this proposal and offer alternatives that we believe will increase the efficiency and quality of anticoagulation management.
华法林被开给数百万美国人用于治疗血栓栓塞，也是不良事件的常见原因。优化华法林治疗一直是国家质量改进计划的重点。已经证明抗凝诊所的治疗效果要好于常规护理。然而，Highmark Medicare Services 最近发布了一份关于抗凝诊所就诊报销的供应商公告，我们认为这将对接受抗凝治疗的患者的护理产生不利影响。在这篇评论中，我们回顾了这一提议的潜在意外后果，并提供了我们认为将提高抗凝管理效率和质量的替代方案。
